PETscanningar

PETscanningar are medical imaging procedures that use positron emission tomography (PET) to visualize metabolic and molecular activity in the body. The technique relies on radiopharmaceuticals—radioactively labeled molecules—that participate in normal biological processes. After administration, the radiotracer distributes according to tissue metabolism, and as the radiotracer decays, emitted positrons collide with electrons, producing pairs of gamma photons that are detected by the PET scanner to generate three-dimensional images of tracer concentration.

Fluorine-18 fluorodeoxyglucose (FDG) is the most widely used tracer, highlighting areas of increased glucose metabolism often seen in tumors, inflamed tissue, and certain brain regions. Patients typically fast for several hours before an FDG PET scan to reduce non-specific uptake, and imaging is performed after an uptake period of about 30 to 60 minutes. Other tracers target specific biological processes, such as neurotransmitter systems, amyloid plaques, or receptor binding, extending PETscanningar to a range of research and clinical applications.

PET is commonly combined with computed tomography (PET/CT) or magnetic resonance imaging (PET/MRI) to provide precise anatomical localization and attenuation correction, enhancing diagnostic accuracy. These hybrid systems are standard in many medical centers and enable better interpretation of metabolic activity in relation to tissue structure.

Clinical uses of PETscanningar are broad. In oncology, they aid in cancer detection, staging, treatment planning, and response assessment. In neurology, they support evaluation of neurodegenerative diseases, epilepsy localization, and brain function studies. In cardiology, they help assess myocardial viability and perfusion. In research, PETscanningar are used to study metabolic processes and disease mechanisms.

Limitations include finite spatial resolution and uptake that is not cancer-specific, which can yield false positives or negatives. Results depend on preparation, scanner calibration, and patient motion. Radiation exposure from the radiotracer and any accompanying CT component is a consideration, particularly for pediatric patients and pregnant individuals. Quantitative measures such as standardized uptake values (SUVs) are used to interpret results with caution and in context.